Medullary Thyroid Cancer (MTC)

Also known as: Thyroid Cancer, Medullary / Medullary Thyroid Carcinoma / Medullary Thyroid Cancer / Parafollicular cell carcinoma (disorder) / Medullary carcinoma with amyloid stroma (morphologic abnormality) / Medullary carcinoma (morphologic abnormality) / Medullary thyroid carcinoma (disorder) / Medullary carcinoma of thyroid

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09292Sacubitril0Recruiting1
DB00177Valsartan0Recruiting1
DB08862Cholecystokinin1Recruiting1
DB00338Omeprazole1Completed1
DB00863Ranitidine1Completed1
DB16568Succinylated gelatin1Completed1
DB00364Sucralfate1Recruiting1
DB05294Vandetanib1Completed1
DB00188Bortezomib1 / 2Terminated1
DB01234Dexamethasone1 / 2Terminated1
DB00145Glycine1 / 2Completed1
DB05381Histamine1 / 2Completed1
DB00836Loperamide1 / 2Unknown Status1
DB11062Octisalate1 / 2Unknown Status1
DB09535Octocrylene1 / 2Unknown Status1
DB15822Pralsetinib1 / 2Recruiting1
DB13017Rovalpituzumab tesirine1 / 2Terminated1
DB15685Selpercatinib1 / 2Recruiting2
DB05294Vandetanib1 / 2Completed1
DB05294Vandetanib1 / 2Terminated1
DB09321Zinc oxide1 / 2Unknown Status1
DB08875Cabozantinib2Terminated1
DB01590Everolimus2Completed1
DB09078Lenvatinib2Terminated1
DB14509Lithium carbonate2Terminated1
DB09079Nintedanib2Completed1
DB06663Pasireotide2Completed1
DB09037Pembrolizumab2Completed1
DB08901Ponatinib2Recruiting1
DB15685Selpercatinib2Active Not Recruiting1
DB00398Sorafenib2Terminated1
DB00398Sorafenib2Withdrawn1
DB05294Vandetanib2Terminated1
DB11885Anlotinib2 / 3Completed1
DB08875Cabozantinib3Recruiting1
DB15685Selpercatinib3Recruiting1
DB05294Vandetanib3Active Not Recruiting1
DB05294Vandetanib3Recruiting1
DB05153Cabozantinib4Active Not Recruiting1
DB08875Cabozantinib4Active Not Recruiting1
DB08875CabozantinibNot AvailableApproved for Marketing1
DB14554DotatateNot AvailableNo Longer Available1
DB15822PralsetinibNot AvailableApproved for Marketing1
DB15685SelpercatinibNot AvailableAvailable1